Tralokinumab Significantly Reduces Work Productivity Impairment and Daily Activity Impairment in Adults With Atopic Dermatitis and Moderate-to-Severe Hand Involvement. J of Skin. 2026;10(2):s726. doi:10.25251/mjfdzc48